openPR Logo
Press release

Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Scope Report Forecast to 2021-27 |key players are Eurofins Advinus, WEX Phamaceuticals Inc., Asahi Kasei Corporation., MediciNova, Inc., Solasia Pharma K.K., ESTEVE, ChromaDex, Inc., Apollo E

09-02-2021 02:46 PM CET | Health & Medicine

Press release from: INFINITY BUSINESS INSIGHTS

This report by Infinity Business Insights covers current treatment methods, developing medications, market share of different therapies, and present and predicted market sizes for Chemotherapy-Induced Peripheral Neuropathy (CIPN) market. Many commonly given chemotherapy and biotherapy medicines, including taxanes, platinum-based therapies, vinca alkaloids, thalidomide, bortezomib, and interferon, can cause chemotherapy-induced peripheral neuropathy (CIPN).

Infinity Business Insights did a thorough research and have brought up this market report that will provide the clients with appropriate data and stats of the moving market predicted and estimated at the best. Rising consumer income, expanding client endeavors, and growing crowd revenue for services are a few of the major factors driving the global market's revenue growth. One of the main factors driving the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market's growth during the forecast period is rising interest for increased utility and functional competence. Another aspect that will aid in the market's growth is the rising demand in the area as a result of the globalisation trend.However, it is necessary to fill in the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Marketindustry's gap with massive initiatives entering the market, which will propel the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market.

Request Sample here for more Information or Any Query Visit:

https://www.infinitybusinessinsights.com/request_sample.php?id=505041

Top company of Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market:

Eurofins Advinus, WEX Phamaceuticals Inc., Asahi Kasei Corporation., MediciNova, Inc., Solasia Pharma K.K., ESTEVE, ChromaDex, Inc., Apollo Endosurgery, Inc., F. & Others.

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Segmentation and Market Scope:

On the basis of product
Calcium Channel Á2-delta Ligands
Antidepressants
Opioids
Others

On the basis of applications
Platinum Agents
Taxanes
Vinca Alkaloids
Others

On the basis of end users
Hospitals
Clinics
Cancer centers

Businesses have reduced operational costs and are now focusing on long-term survival and business continuity. SMEs are expected to increase their adoption of enterprise collaboration solutions in the first quarter of 2021. Different countries, however, have enforced stringent lockdowns, shutdowns, and mobility restrictions in an attempt to prevent the spread of COVID-19. Vendors have been in high demand for the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market since then.

If you have any special requirements, please let us know and we will offer you the report as you want.

Signature:
Amit Jain
Sales Co-Ordinator
International - +1 518 300 3575
Website: https://www.infinitybusinessinsights.com
Facebook: https://facebook.com/Infinity-Business-Insights-352172809160429
LinkedIn: https://www.linkedin.com/company/infinity-business-insights/
Twitter: https://twitter.com/IBInsightsLLP "

ABOUT US
Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.
We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Scope Report Forecast to 2021-27 |key players are Eurofins Advinus, WEX Phamaceuticals Inc., Asahi Kasei Corporation., MediciNova, Inc., Solasia Pharma K.K., ESTEVE, ChromaDex, Inc., Apollo E here

News-ID: 2378913 • Views:

More Releases from INFINITY BUSINESS INSIGHTS

Video Distribution Solutions Market To Witness the Highest Growth Globally in Coming Years 2025-2033 | Brightcove Inc., Kaltura Inc., Haivision Inc.
Video Distribution Solutions Market To Witness the Highest Growth Globally in Co …
Infinity Business Insights has newly added the Video Distribution Solutions Market report 2025-2033 to acquire a stronger and more effective company view. This includes looking into previous progress, current market scenarios, and future potential. Accurate information about the Products, strategies, and market share of the market's main firms is provided. This study provides a comprehensive perspective of the competitive landscape in the global market. The research also forecasts the size and
Analog Design Services Market Size, Share, Analysis, Demand, and Forecast 2025 to 2033 | Analog Devices, Texas Instruments, Maxim Integrated
Analog Design Services Market Size, Share, Analysis, Demand, and Forecast 2025 t …
Infinity Business Insights has newly added the Analog Design Services Market report 2025-2033 to acquire a stronger and more effective company view. This includes looking into previous progress, current market scenarios, and future potential. Accurate information about the Products, strategies, and market share of the market's main firms is provided. This study provides a comprehensive perspective of the competitive landscape in the global market. The research also forecasts the size and
Solar Panel Recycling Market Size And Booming Worldwide From 2025-2033 | Veolia, First Solar Recycling, PV Cycle
Solar Panel Recycling Market Size And Booming Worldwide From 2025-2033 | Veolia, …
Infinity Business Insights has newly added the Solar Panel Recycling Market report 2025-2033 to acquire a stronger and more effective company view. This includes looking into previous progress, current market scenarios, and future potential. Accurate information about the Products, strategies, and market share of the market's main firms is provided. This study provides a comprehensive perspective of the competitive landscape in the global market. The research also forecasts the size and
Online File Storage Services Market Survey Report 2025 Along with Statistics, Forecasts till 2033 | Google Drive, Dropbox, Microsoft OneDrive
Online File Storage Services Market Survey Report 2025 Along with Statistics, Fo …
Infinity Business Insights has newly added the Online File Storage Services Market report 2025-2033 to acquire a stronger and more effective company view. This includes looking into previous progress, current market scenarios, and future potential. Accurate information about the Products, strategies, and market share of the market's main firms is provided. This study provides a comprehensive perspective of the competitive landscape in the global market. The research also forecasts the size

All 5 Releases


More Releases for CIPN

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Growing Focus and Marke …
Introduction Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of cancer treatment, caused by damage to peripheral nerves from drugs such as platinum compounds, taxanes, vinca alkaloids, and proteasome inhibitors. CIPN manifests as pain, numbness, tingling, and motor dysfunction, often leading to dose reduction or discontinuation of chemotherapy, which can compromise cancer outcomes. With up to 68% of patients developing CIPN during chemotherapy, this condition represents a significant unmet
Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline 2025: Groundbreaking …
With Chemotherapy Induced Peripheral Neuropathy (CIPN) reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand for safer, more effective treatment options. According to DelveInsight, the Chemotherapy Induced Peripheral Neuropathy (CIPN) pipeline comprises 4+ pharmaceutical and biotech companies actively developing 5+ therapeutic candidates targeting Chemotherapy Induced Peripheral Neuropathy (CIPN). These therapies span various stages of clinical and
Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market 2034: Clinica …
Chemotherapy Induced Peripheral Neuropathy companies working in the market are Egetis Therapeutics, MediciNova, Sonnet Biotherapeutics, MakScientific, MediciNova, Asahi Kasei Pharma Corp., AnnJi Pharmaceutical, EA Pharma, Aptinyx, Sonnet Biotherapeutics Holdings, Toray, Solasia Pharma, Enveric Biosciences, Regenacy Pharmaceuticals, NeuroBo Pharmaceuticals and others. (Albany, USA) DelveInsight's "Chemotherapy Induced Peripheral Neuropathy Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Chemotherapy Induced Peripheral Neuropathy, historical and forecasted epidemiology as well as the
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Set to Experience Unpre …
DelveInsight's "Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report delivers an in-depth understanding of Chemotherapy-Induced Peripheral Neuropathy (CIPN), historical and forecasted epidemiology as well as the Chemotherapy-Induced Peripheral Neuropathy (CIPN) market trends in the India, China, South Korea, Taiwan, and Australia. The Chemotherapy-Induced Peripheral Neuropathy (CIPN) market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the
Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline Analysis Covering Cli …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 13+ key pharma and biotech companies are working on 13+ pipeline drugs in the Chemotherapy Induced Peripheral Neuropathy therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Chemotherapy Induced Peripheral Neuropathy
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Pipeline Analysis (2023) Cover …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 13+ key pharma and biotech companies are working on 13+ pipeline drugs in the Chemotherapy-Induced Peripheral Neuropathy (CIPN) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Chemotherapy-Induced Peripheral Neuropathy (CIPN)